These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25583577)

  • 21. Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.
    Weinger JG; Plaisted WC; Maciejewski SM; Lanier LL; Walsh CM; Lane TE
    Stem Cells; 2014 Oct; 32(10):2690-701. PubMed ID: 24898518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
    Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K; Maeda Y; Shimano K; Murase M; Mochiduki S; Takemoto K; Kakimoto T; Utsumi H; Oshita K; Kataoka H
    J Immunol Res; 2019; 2019():5821589. PubMed ID: 31930150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.
    Kadiombo AT; Maeshima A; Kayakabe K; Ikeuchi H; Sakairi T; Kaneko Y; Hiromura K; Nojima Y
    Am J Physiol Renal Physiol; 2017 Feb; 312(2):F297-F304. PubMed ID: 27881396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glomerular cytokine expression in murine lupus nephritis.
    Tshilela KA; Ikeuchi H; Matsumoto T; Kuroiwa T; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Hiromura K; Nojima Y
    Clin Exp Nephrol; 2016 Feb; 20(1):23-9. PubMed ID: 25985839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autocrine production of IFN-gamma by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice.
    Carvalho-Pinto CE; García MI; Mellado M; Rodríguez-Frade JM; Martín-Caballero J; Flores J; Martínez-A C; Balomenos D
    J Immunol; 2002 Jul; 169(2):1058-67. PubMed ID: 12097414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF.
    Ji J; Xu J; Li F; Li X; Gong W; Song Y; Dou H; Hou Y
    Acta Biochim Biophys Sin (Shanghai); 2016 May; 48(5):411-9. PubMed ID: 27121231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of toll-like receptor-7 exacerbates lupus nephritis by modulating regulatory T cells.
    Gong L; Wang Y; Zhou L; Bai X; Wu S; Zhu F; Zhu YF
    Am J Nephrol; 2014; 40(4):325-44. PubMed ID: 25341693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
    FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of NKG2D and its ligands RAE-1 and H60 on graft-versus-tumor response].
    Li XF; Chen Q; Ye YB; Fan LF; Chen MS; Li JY; Chen HQ; Chen SP; Zhou ZF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):160-4. PubMed ID: 17490545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand.
    Nakamura K; Nakayama M; Kawano M; Amagai R; Ishii T; Harigae H; Ogasawara K
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9421-6. PubMed ID: 23690625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 4 engagement contributes to expression of NKG2D ligands by renal tubular epithelial cells.
    Chen GE; Wu H; Ma J; Chadban SJ; Sharland A
    Nephrol Dial Transplant; 2011 Dec; 26(12):3873-81. PubMed ID: 21555390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
    Schwarting A; Moore K; Wada T; Tesch G; Yoon HJ; Kelley VR
    J Immunol; 1998 Apr; 160(8):4074-81. PubMed ID: 9558118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.